Recent filings by Alembic Pharmaceuticals Limited

Published Title Summary
2026-07-01 18:40:47 Credit Rating Alembic Pharmaceuticals Limited has informed the Exchange about Credit Rating...
Alembic Pharmaceuticals Limited has informed the Exchange about Credit Rating
2026-04-27 13:25:24 Board Meeting Intimation Alembic Pharmaceuticals Limited has informed the Exchange about Board Meeting...
Alembic Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 15-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend.
2025-07-03 17:21:18 Acquisition-XBRL Alembic Pharmaceuticals Limited has informed the Exchange regarding Acquisition...
Alembic Pharmaceuticals Limited has informed the Exchange regarding Acquisition
2025-01-22 16:54:37 Board Meeting Intimation Alembic Pharmaceuticals Limited has informed the Exchange about Board Meeting...
Alembic Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 03-Feb-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2024 and Other business.
2024-10-18 12:04:54 Board Meeting Intimation ALEMBIC PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting...
ALEMBIC PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 07-Nov-2024 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2024 and Other business.
2024-07-25 16:51:48 Board Meeting Intimation ALEMBIC PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting...
ALEMBIC PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 08-Aug-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2024 and Other business.
2024-05-09 14:06:37 Dividend Alembic Pharmaceuticals Limited has informed the Exchange that Board of...
Alembic Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 09, 2024, recommended Final Dividend of 11 per equity share.